Stanley Laman Group Ltd. Has $3.69 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR)

Stanley Laman Group Ltd. raised its stake in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 17.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 186,980 shares of the company's stock after buying an additional 27,511 shares during the period. Stanley Laman Group Ltd. owned 0.26% of Schrödinger worth $3,691,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in SDGR. Greenwood Capital Associates LLC raised its stake in shares of Schrödinger by 2.7% during the first quarter. Greenwood Capital Associates LLC now owns 23,139 shares of the company's stock valued at $457,000 after acquiring an additional 612 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Schrödinger by 118.5% during the first quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after acquiring an additional 3,313 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in shares of Schrödinger by 32.4% during the first quarter. Harbor Capital Advisors Inc. now owns 15,005 shares of the company's stock valued at $296,000 after acquiring an additional 3,676 shares during the last quarter. United Advisor Group LLC raised its stake in shares of Schrödinger by 3.3% during the fourth quarter. United Advisor Group LLC now owns 19,769 shares of the company's stock valued at $381,000 after acquiring an additional 634 shares during the last quarter. Finally, Two Sigma Advisers LP bought a new position in shares of Schrödinger during the fourth quarter valued at $473,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

SDGR has been the subject of several analyst reports. Piper Sandler dropped their price target on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. KeyCorp raised their price target on shares of Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $32.80.

Insider Buying and Selling at Schrödinger

In other Schrödinger news, insider Karen Akinsanya sold 16,723 shares of Schrödinger stock in a transaction on Monday, April 14th. The shares were sold at an average price of $25.09, for a total value of $419,580.07. Following the completion of the sale, the insider now directly owns 15,625 shares of the company's stock, valued at approximately $392,031.25. The trade was a 51.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 8.60% of the company's stock.

Schrödinger Price Performance

NASDAQ SDGR traded down $1.40 during mid-day trading on Friday, reaching $21.43. 1,726,412 shares of the stock were exchanged, compared to its average volume of 896,755. Schrödinger, Inc. has a one year low of $16.60 and a one year high of $28.47. The stock has a 50 day simple moving average of $23.57 and a 200-day simple moving average of $22.41. The stock has a market cap of $1.57 billion, a P/E ratio of -9.16 and a beta of 1.63.

Schrödinger (NASDAQ:SDGR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.01). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm had revenue of $59.55 million for the quarter, compared to the consensus estimate of $54.60 million. During the same period in the prior year, the business earned ($0.86) EPS. Schrödinger's quarterly revenue was up 62.7% on a year-over-year basis. Sell-side analysts anticipate that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.